Concorde Asset Management, LLC Abbott Laboratories Transaction History
Concorde Asset Management, LLC
- $183 Million
- Q4 2024
A detailed history of Concorde Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Concorde Asset Management, LLC holds 2,148 shares of ABT stock, worth $269,788. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,148
Previous 2,146
0.09%
Holding current value
$269,788
Previous $244,000
0.82%
% of portfolio
0.13%
Previous 0.14%
Shares
15 transactions
Others Institutions Holding ABT
# of Institutions
3,377Shares Held
1.33BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.69 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.54 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.79 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $220B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...